InsidersTradesSigma
우진비앤지 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 우진비앤지 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 우진비앤지 has recorded 43 insider filings. Market capitalisation: €18.1bn. The latest transaction was filed on 15 July 2026 (Purchase). Among the most active insiders: 강재구. The full history is free.
41
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,317 of 28,199 companies
36.9
score / 100
Value49
Quality25
FCF yld6.0%
Earn yld-10%
EV/EBITDA9.7x
ROE·
Gross mgn30%
Net mgn-3.2%
Debt/EBITDA6.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 15 July 2026
Declarations43 total
Other
Other(filed)
Other
Other(filed)
25 of 43 declarations
About 우진비앤지
우진비앤지 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.